Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-12

FDA Approved: HALOPERIDOL DECANOATE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved haloperidol decanoate from Sagent Pharmaceuticals under the original application, a long-acting injectable antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

ORIG AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)